Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365961 · ClinicalTrials.gov registry record · Phase 4
Hip Scope Fascia-iliaca (FI) Block Study
A Phase 4 study, sponsored by The Hawkins Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT02365961: Completed Phase 4 study, sponsored by The Hawkins Foundation.
NCT02365961 is a Phase 4 study that has completed, run by The Hawkins Foundation. The registered enrollment target is 84 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02365961, a Phase 4 study, has completed, sponsored by The Hawkins Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.
Primary Outcome
Pain, as measured by Visual Analog Scale (VAS). Scores are ranged from 0-10, 0 is no pain and 10 is worst possible pain. The unit of measure is units on a scale.
Interventions
- DRUG Epinephrine
- DRUG clonidine
- DRUG ropivicaine
- DRUG Noropin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
What the finished NCT02365961 record still lists
NCT02365961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 4 interventions - of which Epinephrine is the first listed.
NCT02365961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02365961 about?
NCT02365961 is a clinical study titled "Hip Scope Fascia-iliaca (FI) Block Study". Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.
What is the current status of trial NCT02365961?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2015-04. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02365961?
The interventions under investigation include: Epinephrine (DRUG), clonidine (DRUG), ropivicaine (DRUG), Noropin (DRUG).
Who is sponsoring clinical trial NCT02365961?
This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02365961's enrollment target sits among peer trials
84 929th of 2000 higher than 1,064 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia